Deborah Telman is exiting months after the company paid $202 million to settle allegations that it provided illegal kickbacks to health care providers to juice sales of its HIV drugs.
Deborah Telman is exiting months after the company paid $202 million to settle allegations that it provided illegal kickbacks to health care providers to juice sales of its HIV drugs.
